CJC-1295 (no DAC)

Mod GRF 1-29

Peptide peptide SubQ Published Clinical Data

Half-life

30 min

Time to Peak

15 min

Steady State

~1 days

Dose Range

100–300 mcg

Frequency

Daily

Overview

Modified Growth Hormone Releasing Factor (1-29). A truncated GHRH analog with four amino acid substitutions for increased stability. Often combined with Ipamorelin for synergistic GH release. Requires reconstitution with bacteriostatic water (BAC water) before use. Store lyophilized powder refrigerated; once reconstituted, use within 4-6 weeks.

Mechanism of Action

Binds GHRH receptors on the anterior pituitary to stimulate growth hormone release in a pulsatile, physiological manner without raising cortisol or prolactin significantly.

Dosing Information

Route	Dose Range	Half-life	Tmax	Frequency
Subcutaneous (SubQ)	100–300 mcg	30 min	15 min	Daily, Twice daily

Storage & Handling

2-8C — Store lyophilized powder refrigerated. Reconstitute with BAC water. Use reconstituted solution within 4-6 weeks.

Used in Regimens

1 regimen

GH Peptide Stack — CJC + Ipamorelin

CJC-1295 (no DAC) paired with Ipamorelin to amplify natural growth hormone pulses. The most widely used GHRH + GHRP combination for body composition, sleep quality, and recovery. Run 5 days on, 2 days off.

CJC-1295 no-DAC at 100mcg — inject simultaneously with Ipamorelin

12wk peptide

Primary

Data Sources

Peer-reviewed Pharmacokinetics of modified GRF 1-29 analogs

Related Tools

Medication Level Plotter

See blood level curves for this compound

Dose Calculator

Calculate reconstitution and draw volumes

Split Dose Calculator

Divide your weekly dose into multiple injections

Track CJC-1295 (no DAC) with Doseline

Reminders, medication level charts, injection site rotation, and protocol tracking — all free, all private.

Join the waitlist

Doseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.